Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: A study with allergen-specific human helper T cells

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 SUPPL., 1997, Pages

  Mori, Akio ^a   Kaminuma, Osamu ^a   Suko, Matsunobu ^a   Mikami, Tadashi ^a   Nishizaki, Yoko ^a   Ohmura, Takeo ^a   Hoshino, Akihiko ^a   Asakura, Yumiko ^a   Miyazawa, Keiji ^a   Ando, Toru ^a   Okumura, Yasushi ^a   Yamamoto, Kazuhiko ^a   Okudaira, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atopic disease; Bronchial asthma; IL 5; T cell

Indexed keywords

ALLERGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR;

ALLERGIC ASTHMA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; HUMAN CELL; HYBRIDOMA; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONE CELLS; HUMANS; HYBRIDOMAS; HYPERSENSITIVITY; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MITES; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 17444447607     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70006-X     Document Type: Article

References (36)

1. Azzawi M, Bradley BO, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1410-3.
2. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
3. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
4. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
5. +) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis 1992;145:S22-6.
6. Kirby JG, Hargreave FE, Gleich GJ, O'Byrne PM. Brochoalveolar cell profiles of asthmatic subjects. Am Rev Respir Dis 1987;136:379-83.
7. Corrigan CT, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-6.
8. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and non-allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
9. Corrigan CJ, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993;47:540-7.
10. Hamid Q, Azzawi M, Sun Ying Moqbel R, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
11. 2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
12. Krishnaswamy G, Liu MC, Su S-N, et al. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am J Respir Cell Mol Biol 1993;9:279-86.
13. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced latephase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
14. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 1995;7:449-57.
15. Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K. Enhanced production and gene expression of IL-5 in bronchial asthma-management of atopic diseases with agents that down regulate IL-5 gene transcription. ACI News 1994;6:19-25.
16. Mori A, Suko M, Tsuruoka N, et al. Atopic diseases and eosinophilic inflammation- Possible management with downregulation of IL-5 gene transcription. Environ Dermatol 1994;1:42-54.
17. Sheffer AL (Chairman). International consensus report on diagnosis and management of asthma. Clin Exp Allergy 1992;22S:1-72.
18. Yuuki T, Okumura Y, Ando T, et al. Cloning and expression of cDNA for the major house dust mite allergen Der f II in Escherichia coli Agric Biol Chem 1991;55:1233-8.
19. Mori A, Suko M, Kaminuma O, et al. IL-15 promotes cytokine production of human helper T cells. J Immunol 1996;156:2391-6.
20. Mori A, Inoue S, Mikami T, et al. Analysis of human IL-5 gene transcription by T cell clones and hybridomas. Int Arch Allergy Immunol 1995;107:366-7.
21. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Tanabe T, Konishi M, Mizuta T, Noma T, Honjo T. Molecular cloning and structure of the human interleukin-5 gene. J Biol Chem 1987;262:16580-4.
23. Fujita T, Shibuya H, Ohashi T, Yamanishi K, Taniguchi T. Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 1986;46:401-7.
24. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary latephase reaction. Am Rev Respir Dis 1993;147:901-7.
25. Danielle RP. Pathophysiology of the asthmatic syndromes. In: Danielle RP, editor. Immunologic diseases of the lung. Boston: Blackwell Scientific, 1988:503-16.
26. Walker C, Virchow Jr. JC, Bruijnzeel PLB, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146:1829-35.
27. Bentley AM, Menz G, Storz C, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am Rev Respir Dis 1992;146:500-6.
28. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dematitis. Lancet 1994;344:883.
29. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 1990;59:783-836.
30. Durand DB, Morgan MR, Wiss A, Crabtree GR. A 275 base pair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J Exp Med 1987;165:395-407.
31. Riegel JS, Corthesy B, Flanagan WM, Crabtree GR. Regulation of the interleukin-2 gene. In: Kishimoto T, editor. Chemical Immunology. Vol. 51. Basel: Karger, 1992:266-98.
32. Sigal NH, Dumont FJ. Cyclosporin A, FK506 and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol 1992;10:519-60.
33. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-41.
34. Vacca A, Fellim MP, Farina AR, et al. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992;175:637-46.
35. Weinberger C, Hollenberg SM, Ong ES, et al. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 1985;228:740-2.
36. Okudaira H, Mori A, Suko M, Ito K. Selective suppression of IL-5 synthesis by OM-01. Int Arch Allergy Immunol 1997;113:331-4.